Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010;6(2):Article 2.
doi: 10.2202/1557-4679.1211.

Targeted maximum likelihood based causal inference: Part I

Affiliations

Targeted maximum likelihood based causal inference: Part I

Mark J van der Laan. Int J Biostat. 2010.

Abstract

Given causal graph assumptions, intervention-specific counterfactual distributions of the data can be defined by the so called G-computation formula, which is obtained by carrying out these interventions on the likelihood of the data factorized according to the causal graph. The obtained G-computation formula represents the counterfactual distribution the data would have had if this intervention would have been enforced on the system generating the data. A causal effect of interest can now be defined as some difference between these counterfactual distributions indexed by different interventions. For example, the interventions can represent static treatment regimens or individualized treatment rules that assign treatment in response to time-dependent covariates, and the causal effects could be defined in terms of features of the mean of the treatment-regimen specific counterfactual outcome of interest as a function of the corresponding treatment regimens. Such features could be defined nonparametrically in terms of so called (nonparametric) marginal structural models for static or individualized treatment rules, whose parameters can be thought of as (smooth) summary measures of differences between the treatment regimen specific counterfactual distributions. In this article, we develop a particular targeted maximum likelihood estimator of causal effects of multiple time point interventions. This involves the use of loss-based super-learning to obtain an initial estimate of the unknown factors of the G-computation formula, and subsequently, applying a target-parameter specific optimal fluctuation function (least favorable parametric submodel) to each estimated factor, estimating the fluctuation parameter(s) with maximum likelihood estimation, and iterating this updating step of the initial factor till convergence. This iterative targeted maximum likelihood updating step makes the resulting estimator of the causal effect double robust in the sense that it is consistent if either the initial estimator is consistent, or the estimator of the optimal fluctuation function is consistent. The optimal fluctuation function is correctly specified if the conditional distributions of the nodes in the causal graph one intervenes upon are correctly specified. The latter conditional distributions often comprise the so called treatment and censoring mechanism. Selection among different targeted maximum likelihood estimators (e.g., indexed by different initial estimators) can be based on loss-based cross-validation such as likelihood based cross-validation or cross-validation based on another appropriate loss function for the distribution of the data. Some specific loss functions are mentioned in this article. Subsequently, a variety of interesting observations about this targeted maximum likelihood estimation procedure are made. This article provides the basis for the subsequent companion Part II-article in which concrete demonstrations for the implementation of the targeted MLE in complex causal effect estimation problems are provided.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Abadie A, Imbens GW. Large sample properties of matching estimators for average treatment effects. Econometrica. 2006;74:235–67. doi: 10.1111/j.1468-0262.2006.00655.x. - DOI
    1. Andersen PK, Borgan O, Gill RD, Keiding N. Statistical Models Based on Counting Processes. Springer-Verlag; New York: 1993.
    1. Bembom O, Petersen ML, Rhee S-Y, Fessel WJ, Sinisi SE, Shafer RW, van der Laan MJ. Biomarker discovery using targeted maximum likelihood estimation: Application to the treatment of antiretroviral resistant hiv infection. Statistics in Medicine. page http://www3.interscience.wiley.com/journal/121422393/abstract, 2008. - PMC - PubMed
    1. Bembom O, van der Laan MJ, Haight T, Tager IB. Lifetime and current leisure time physical activity and all-cause mortality in an elderly cohort. Epidemiology. 2009 doi: 10.1097/EDE.0b013e31819e3f28. - DOI - PMC - PubMed
    1. Bembom Oliver, van der Laan Mark. Statistical methods for analyzing sequentially randomized trials, commentary on jnci article adaptive therapy for androgen independent prostate cancer: A randomized selection trial including four regimens, by peter f. thall, c. logothetis, c. pagliaro, s. wen, m.a. brown, d. williams, r. millikan 2007. Journal of the National Cancer Institute. 2007;99(21):1577–1582. doi: 10.1093/jnci/djm185. - DOI - PMC - PubMed